I really liked the first paragraph of the Q that Crunch posted, about getting an EUA for a non-covid test platform. We researched QD assays and tests ten years ago and POC units. Now imagine rapid cancer, disease and blood tests that can all be read by a small device in a doctor's office and connected to a QMC HealthID DLT adapted either to outpatient care or clinical trial testing. It's an ecosystem.
Company is full speed ahead.